Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
depression
5
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
boston
major depressive disorder
new york blog main
new york top stories
blackstone group
clinical trials
david goldstein
epilepsy
essential tremor
kiran reddy
medicine
neuroscience
perimenopausal depression
praxis precision medicines
sage therapeutics
san francisco blog main
san francisco top stories
steven petrou
aligos therapeutics
antidepressant
antisense oligonucleotide
assurex health
baker brothers life sciences
benzodiazepine
benzodiazepines
biogen
biomarkers
biotech ipos
blackstone life sciences
blepharitis
boulder/denver blog main
boulder/denver top stories
brca-1
What
depression
precision
research
drugs
genetic
medical
medicines
new
praxis
trial
way
aims
alto
announced
approval
backed
biotechs
brexanalone
cancer
cause
centers
central
ceo
cerebral
clinical
cns
cut
decentralized
disorder
drug
earnest
embarked
emerged
epilepsy
event
fda
forced
forefront
genes
guesswork
Language
unset
Current search:
depression
×
biotech
×
@techcrunch.com
2 years ago
How Cerebral and Alto Neuroscience embarked on an at-home clinical trial for depression
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?